IVY Mahsciao – Trademark Portfolio

Entity Type: 01

IVY Mahsciao holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 3 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include EVRMORE and EMPATHY AI. The owner is based in New York, NY.

1 West Street, Apt. 2431

New York, NY 10004

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

EVRMORE
EVRMORE
Registered 2023
EVRMORE
EVRMORE
Abandoned 2020

Trademark Classifications

IVY Mahsciao's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (3 filings)

Scientific and technological services; industrial analysis and research services

9
Computers & Electronics (3 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does IVY Mahsciao have?

IVY Mahsciao has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.

What trademark classes does IVY Mahsciao file in?

IVY Mahsciao files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.

What are IVY Mahsciao's most well-known trademarks?

IVY Mahsciao's registered trademark portfolio includes well-known marks such as EVRMORE and EMPATHY AI. These are among 2 currently registered trademarks in the portfolio.

What is IVY Mahsciao's trademark registration success rate?

IVY Mahsciao has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.